Preparation and mucoadhesive test of CSA-loaded liposomes with different characteristics for the intestinal lymphatic delivery

被引:11
作者
Kim, HJ
Lee, CM
Lee, YB
Lee, KY [1 ]
机构
[1] Chonnam Natl Univ, Fac Appl Chem Engn, Kwangju 500757, South Korea
[2] Chonnam Natl Univ, Res Inst Catalysis, Kwangju 500757, South Korea
[3] Chonnam Natl Univ, Interdisciplinary Program Biomed Engn, Kwangju 500757, South Korea
[4] Chonnam Natl Univ, Dept Pharm, Kwangju 501190, South Korea
关键词
CSA; liposome; intestinal lymphatics; mucoadhesive;
D O I
10.1007/BF02932287
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Drug delivery to the lymphatic system may be important in terms of the treatment with lymphatic involvement, such as tumor metastases and immunization. Especially, drug transport via the intestinal lymphatics after oral administration has been attracted lots of interests. The purpose of this study was to prepare cyclosporin A (CSA)-loaded liposomes, with different characteristics, and evaluate their mucoadhesivity. Three liposome preparations were formulated: cationic stearylamine liposomes (SA-Lip), anionic phosphatidylserine liposomes (PS-Lip), polymer (chitosan)-coated liposomes (CS-Lip), and characterized. The liposome preparations were found to be spherical in shape, with PS-Lip being the smallest. The liposome preparations exhibited entrapment efficiencies in the order: PS-Lip (52.5 +/- 2.9%) > SA-Lip (48.8 +/- 3.3%) > CS-Lip (41.7 +/- 4.2%). Finally, mucoadhesive tests were carried out using rat intestine, with SA-Lip (67%) showing the best adhesive rate of the three preparations (PS-Lip: 56%, CS-Lip: 61%). These results suggest that a positive charge on the surface of drug carriers may be an important factor for the intestinal drug delivery.
引用
收藏
页码:516 / 521
页数:6
相关论文
共 22 条
[1]   CHARACTERIZATION, STABILITY AND IN-VIVO TARGETING OF LIPOSOMAL FORMULATIONS CONTAINING CYCLOSPORINE [J].
ALANGARY, AA ;
BAYOMI, MA ;
KHIDR, SH ;
ALMESHAL, MA ;
ALDARDIRI, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 114 (02) :221-225
[2]   STABILITY OF LIPOSOMES IN-VITRO AND THEIR UPTAKE BY RAT PEYER PATCHES FOLLOWING ORAL-ADMINISTRATION [J].
ARAMAKI, Y ;
TOMIZAWA, H ;
HARA, T ;
YACHI, K ;
KIKUCHI, H ;
TSUCHIYA, S .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1228-1231
[3]   LIPOSOMAL DRUG DELIVERY - ADVANTAGES AND LIMITATIONS FROM A CLINICAL PHARMACOKINETIC AND THERAPEUTIC PERSPECTIVE [J].
FIELDING, RM .
CLINICAL PHARMACOKINETICS, 1991, 21 (03) :155-164
[4]   THE INCREASED EFFICACY AND DECREASED NEPHROTOXICITY OF A CYCLOSPORINE LIPOSOME [J].
FREISE, CE ;
LIU, T ;
HONG, KL ;
OSORIO, RW ;
PAPAHADJOPOULOS, D ;
FERRELL, L ;
ASCHER, NL ;
ROBERTS, JP .
TRANSPLANTATION, 1994, 57 (06) :928-932
[5]   Chitosan-coated liposomes: characterization and interaction with leuprolide [J].
Guo, J ;
Ping, Q ;
Jiang, G ;
Huang, L ;
Tong, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 260 (02) :167-173
[6]  
HASHIDA M, 1997, J PHARMACOKIN BIOPHA, V5, P223
[7]   COMPARATIVE, QUANTITATIVE STUDY OF LYMPHOID AND NONLYMPHOID UPTAKE OF 60 NM POLYSTYRENE PARTICLES [J].
HILLERY, AM ;
JANI, PU ;
FLORENCE, AT .
JOURNAL OF DRUG TARGETING, 1994, 2 (02) :151-156
[8]   LYMPHATIC TRANSPORT OF LIPOSOME-ENCAPSULATED AGENTS - EFFECTS OF LIPOSOME SIZE FOLLOWING INTRAPERITONEAL ADMINISTRATION [J].
HIRANO, K ;
HUNT, CA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (09) :915-921
[9]   Utilizing bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles [J].
Hussain, N ;
Florence, AT .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :153-156
[10]   Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat [J].
Hussain, N ;
Jani, PU ;
Florence, AT .
PHARMACEUTICAL RESEARCH, 1997, 14 (05) :613-618